Videos

RSS icon
To hear about key trends in cardiac imaging, Cardiovascular Business spoke with two experts in cardiac imaging at American College of Cardiology (ACC) 2023 meeting, Marcelo DiCarli, MD, chief, division of nuclear medicine and molecular imaging, executive director for the cardiovascular imaging program, Brigham and Women's Hospital, and Rob Beanlands, MD, is director of the National Cardiac PET Centre at the University of Ottawa Heart Institute, Canada.

What's new in cardiac imaging? 2 experts discuss the latest trends

Marcelo DiCarli, MD, and Rob Beanlands, MD, shared their thoughts on the current state of cardiac imaging at ACC.23. 

James Muller MD discusses vulnerable plaque and nuclear weapons as recipient of ACC Distinguished Scientist award. The right image in the near infrared spectroscopy system he developed to find vulnerable plaques.

Nobel Prize-winning cardiologist on his quest to find and treat vulnerable plaques

Pioneering cardiologist James Muller, MD, a winner of the Nobel Peace Prize, was one of the chief researchers that developed the concept of vulnerable plaques causing heart attacks. He was recently honored by the American College of Cardiology for his contributions.

Paul M. Ridker, MD, MPH, director of the Center for Cardiovascular Disease Prevention, and the Eugene Braunwald Professor of Medicine, cardiovascular medicine, Brigham and Women's Hospital, who presented the results of late-breaking study on residual inflammatory risk in contemporary statin treated patients. The study used an analyses of 31,197 patients in the PROMINENT, REDUCE-IT and STRENGTH trials. 

What new data can teach cardiologists about statin use and treating inflammation

"If we do not attack the inflammation, we just are not going to get the best outcomes for our patients," one researcher told Cardiovascular Business. 

Janet Wei at Cedars-Sinai Hospital explains INOCA and MINOCA at ACC 2023.

Understanding INOCA and MINOCA epidemiology

Janet Wei, MD, associate medical director of the Biomedical Imaging Research Institute, and co-director of the stress echocardiography lab at Cedars-Sinai Hospital, explains the current information on the INOCA and MINOCA.

Raj Makkar, MD, Cedars-Sinai’s vice president of Cardiovascular Innovation and Intervention and the Stephen R. Corday, MD, Chair in Interventional Cardiology, explains the ACC 2023 results on the safety and efficacy of transcatheter edge-to-edge mitral valve repair in degenerative mitral regurgitation (MR) study. It was a review of data is from the STS/ACC TVT Registry that was presented at the American College of Cardiology (ACC) 2023 meeting.

New data on real-world TEER outcomes in patients with degenerative MR

TEER can significantly improve a patient's chances of survival, new findings confirm.

Marielle Scherrer Crosbie and Tomas Neilan explain the STOP-CA trial and how statins can help prevent cardiotoxicity from anthracycline chemo agents.

Statins may help prevent anthracycline cardiotoxicity in chemotherapy

The STOP-CA trial showed that statins can help chemotherapy patients avoid potential side effects related to anthracycline agents. Co-principal investigators Marielle Scherrer-Crosbie, MD, and Tomas Neilan, MD, discussed the details of that trial at ACC.23. 

VIDEO: American Society of Nuclear Cardiology (ASNC) President Mouaz Al-Mallah, MD, chair of cardiovascular PET and associate director of nuclear cardiology, Houston Methodist DeBakey Heart and Vascular Center, and ASNC President-elect Larry Phillips, MD, director of nuclear cardiology, NYU Langone, outline the new technologies available and why upgrading cardiac nuclear labs matters and what is the ROI. #ASNC

What is the ROI for upgrading nuclear cardiology labs?

Some nuclear cardiology labs are still using SPECT systems that are 20-25 years old. Is it time to make an upgrade? 

Watch the VIDEO ASNC President Mouaz Al-Mallah explains trends in nuclear cardiology. American Society of Nuclear Cardiology sees future opportunities in nuclear imaging outside of perfusion imaging. #ASNC

ASNC leaders reflect on the state of nuclear cardiology

ASNC President Mouaz Al-Mallah, MD, and ASNC President-elect Larry Phillips, MD, discussed some of the key trends in cardiac molecular imaging at ACC.23. 

Displaying 185 - 192 of 345

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.